Atomistry » Fluorine » PDB 5olw-5p92 » 5oq4
Atomistry »
  Fluorine »
    PDB 5olw-5p92 »
      5oq4 »

Fluorine in PDB 5oq4: PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology

Enzymatic activity of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology

All present enzymatic activity of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology:
2.7.1.153; 2.7.11.1;

Protein crystallography data

The structure of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology, PDB code: 5oq4 was solved by R.L.Williams, X.Zhang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 61.00 / 2.70
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 139.490, 67.360, 103.610, 90.00, 96.94, 90.00
R / Rfree (%) 19.6 / 26.4

Fluorine Binding Sites:

The binding sites of Fluorine atom in the PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology (pdb code 5oq4). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology, PDB code: 5oq4:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 5oq4

Go back to Fluorine Binding Sites List in 5oq4
Fluorine binding site 1 out of 3 in the PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1201

b:60.0
occ:1.00
 FBB A:A3W1201 0.0 60.0 1.0
CAW A:A3W1201 1.3 55.3 1.0
FAS A:A3W1201 2.0 54.0 1.0
FAX A:A3W1201 2.1 48.3 1.0
CAV A:A3W1201 2.4 56.1 1.0
NAP A:A3W1201 2.7 58.7 1.0
CAU A:A3W1201 3.0 56.5 1.0
CAQ A:A3W1201 3.2 52.0 1.0
CBA A:A3W1201 3.4 56.3 1.0
CAI A:A3W1201 3.7 68.6 1.0
CAK A:A3W1201 3.8 57.4 1.0
OG A:SER806 3.9 90.2 1.0
CE A:MET804 4.1 96.0 1.0
NAJ A:A3W1201 4.2 63.6 1.0
CB A:SER806 4.3 98.7 1.0
CAT A:A3W1201 4.3 58.3 1.0
NAR A:A3W1201 4.6 46.3 1.0
CAZ A:A3W1201 4.7 56.0 1.0
OD2 A:ASP964 4.7 55.2 1.0
NZ A:LYS833 4.7 63.1 1.0
CG A:PRO810 4.7 71.2 1.0
NAY A:A3W1201 5.0 59.3 1.0
NAL A:A3W1201 5.0 46.7 1.0

Fluorine binding site 2 out of 3 in 5oq4

Go back to Fluorine Binding Sites List in 5oq4
Fluorine binding site 2 out of 3 in the PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1201

b:54.0
occ:1.00
 FAS A:A3W1201 0.0 54.0 1.0
CAW A:A3W1201 1.3 55.3 1.0
FBB A:A3W1201 2.0 60.0 1.0
FAX A:A3W1201 2.2 48.3 1.0
CAV A:A3W1201 2.4 56.1 1.0
CBA A:A3W1201 2.8 56.3 1.0
CD A:LYS833 3.0 56.7 1.0
NZ A:LYS833 3.0 63.1 1.0
CE A:LYS833 3.3 59.9 1.0
CAU A:A3W1201 3.7 56.5 1.0
CG A:PRO810 4.0 71.2 1.0
CAZ A:A3W1201 4.2 56.0 1.0
CB A:PRO810 4.3 71.0 1.0
CG A:LYS833 4.3 55.9 1.0
NAP A:A3W1201 4.4 58.7 1.0
OD2 A:ASP836 4.4 63.0 1.0
CAQ A:A3W1201 4.5 52.0 1.0
CE A:MET804 4.5 96.0 1.0
CB A:SER806 4.5 98.7 1.0
OG A:SER806 4.5 90.2 1.0
CD A:PRO810 4.7 74.0 1.0
CAT A:A3W1201 4.7 58.3 1.0
CB A:LYS833 4.7 55.3 1.0
NAY A:A3W1201 5.0 59.3 1.0

Fluorine binding site 3 out of 3 in 5oq4

Go back to Fluorine Binding Sites List in 5oq4
Fluorine binding site 3 out of 3 in the PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of PQR309 - A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1201

b:48.3
occ:1.00
 FAX A:A3W1201 0.0 48.3 1.0
CAW A:A3W1201 1.4 55.3 1.0
FBB A:A3W1201 2.1 60.0 1.0
FAS A:A3W1201 2.2 54.0 1.0
CAV A:A3W1201 2.3 56.1 1.0
CAU A:A3W1201 2.8 56.5 1.0
CAQ A:A3W1201 3.0 52.0 1.0
NAP A:A3W1201 3.0 58.7 1.0
CE A:MET804 3.3 96.0 1.0
CBA A:A3W1201 3.5 56.3 1.0
CG2 A:ILE831 3.8 47.6 1.0
CD1 A:ILE831 3.9 46.6 1.0
NAR A:A3W1201 3.9 46.3 1.0
CAK A:A3W1201 4.0 57.4 1.0
CAT A:A3W1201 4.1 58.3 1.0
CG A:PRO810 4.2 71.2 1.0
CB A:PRO810 4.2 71.0 1.0
CD1 A:ILE879 4.4 41.6 1.0
CD A:LYS833 4.5 56.7 1.0
SD A:MET804 4.6 92.8 1.0
CAM A:A3W1201 4.6 46.8 1.0
CAZ A:A3W1201 4.6 56.0 1.0
CB A:ILE831 4.7 46.7 1.0
CG1 A:ILE831 4.7 47.6 1.0
NAL A:A3W1201 4.7 46.7 1.0
CAI A:A3W1201 4.7 68.6 1.0
OG A:SER806 4.8 90.2 1.0
NAJ A:A3W1201 4.8 63.6 1.0
NAY A:A3W1201 4.9 59.3 1.0
NZ A:LYS833 5.0 63.1 1.0

Reference:

F.Beaufils, N.Cmiljanovic, V.Cmiljanovic, T.Bohnacker, A.Melone, R.Marone, E.Jackson, X.Zhang, A.Sele, C.Borsari, J.Mestan, P.Hebeisen, P.Hillmann, B.Giese, M.Zvelebil, D.Fabbro, R.L.Williams, D.Rageot, M.P.Wymann. 5-(4,6-Dimorpholino-1,3,5-Triazin-2-Yl)-4-(Trifluoromethyl) Pyridin-2-Amine (PQR309), A Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/Mtor Inhibitor As Clinical Candidate in Oncology. J. Med. Chem. V. 60 7524 2017.
ISSN: ISSN 1520-4804
PubMed: 28829592
DOI: 10.1021/ACS.JMEDCHEM.7B00930
Page generated: Thu Aug 1 12:31:17 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy